Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000125675 | SCV000169137 | benign | not specified | 2014-05-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000233141 | SCV000285358 | benign | Tuberous sclerosis 2 | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000055465 | SCV000395630 | benign | Tuberous sclerosis syndrome | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Athena Diagnostics | RCV000125675 | SCV001880087 | benign | not specified | 2021-03-16 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000233141 | SCV002039347 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002256037 | SCV002533430 | benign | Hereditary cancer-predisposing syndrome | 2021-04-21 | criteria provided, single submitter | curation | |
Ce |
RCV002262609 | SCV002545715 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | TSC2: BS2 |
KCCC/NGS Laboratory, |
RCV000233141 | SCV004016115 | benign | Tuberous sclerosis 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000233141 | SCV004018706 | benign | Tuberous sclerosis 2 | 2023-07-06 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. Homozygosity has been confirmed in one or more individuals. As homozygosity for pathogenic variants in this gene is generally assumed to result in embryonic lethality, this variant is unlikely to be pathogenic. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV002262609 | SCV004221439 | benign | not provided | 2021-03-16 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000055465 | SCV004815791 | benign | Tuberous sclerosis syndrome | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Tuberous sclerosis database |
RCV000055465 | SCV000083686 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation |